Skip to content
healthcare.dev

ADENOSINE

NDC 51662-1631, ADENOSINE, injection, from HF Acquisition Co LLC, DBA HealthFirst.

Product NDC
51662-1631
Status
Listed
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078686
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1631 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADENOSINE3 mg/mL

Pharmacologic classes

Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]

Package NDCNDC-11Package
51662-1631-1516621631012 mL in 1 VIAL, SINGLE-DOSE (51662-1631-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fa6eb0f8-7c41-2e17-e053-6294a90ac8ca

Use it

Look up 51662-1631 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1631 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51662-1631. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.